Freedman O - Search Results

1

Filling in the gaps: reporting of concurrent supportive care therapies in breast cancer chemotherapy trials.

Freedman O, Amir E, Zimmermann C, Clemons M. Freedman O, et al. Support Care Cancer. 2011 Mar;19(3):315-22. doi: 10.1007/s00520-010-1069-5. Epub 2011 Jan 4. Support Care Cancer. 2011. PMID: 21203780 Review.

2

Treatment of locally advanced breast cancer.

Verma S, Clemons M, Fitzgerald B, Freedman O. Verma S, et al. Among authors: freedman o. CMAJ. 2004 Aug 3;171(3):219; author reply 221-2. doi: 10.1503/cmaj.1040532. CMAJ. 2004. PMID: 15289404 Free PMC article. No abstract available.

3

Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?

Freedman OC, Verma S, Clemons MJ. Freedman OC, et al. Cancer Treat Rev. 2005 Feb;31(1):1-17. doi: 10.1016/j.ctrv.2004.09.008. Epub 2004 Nov 18. Cancer Treat Rev. 2005. PMID: 15707700 Review.

4

Pre-menopausal breast cancer and aromatase inhibitors: Treating a new generation of women.

Freedman OC, Verma S, Clemons MJ. Freedman OC, et al. Breast Cancer Res Treat. 2006 Oct;99(3):241-7. doi: 10.1007/s10549-006-9208-x. Epub 2006 Jun 3. Breast Cancer Res Treat. 2006. PMID: 16752075 Review.

5

Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer?

Bedard PL, Freedman OC, Howell A, Clemons M. Bedard PL, et al. Breast Cancer Res Treat. 2008 Apr;108(3):307-17. doi: 10.1007/s10549-007-9606-8. Epub 2007 May 22. Breast Cancer Res Treat. 2008. PMID: 18351454 Review.

6

Automated CT-based analysis to detect changes in the prevalence of lytic bone metastases from breast cancer.

Skrinskas T, Clemons M, Freedman O, Weller I, Whyne CM. Skrinskas T, et al. Among authors: freedman o. Clin Exp Metastasis. 2009;26(2):97-103. doi: 10.1007/s10585-008-9219-6. Epub 2008 Oct 22. Clin Exp Metastasis. 2009. PMID: 18941910

7

Approach to inflammatory breast cancer.

Molckovsky A, Fitzgerald B, Freedman O, Heisey R, Clemons M. Molckovsky A, et al. Among authors: freedman o. Can Fam Physician. 2009 Jan;55(1):25-31. Can Fam Physician. 2009. PMID: 19155362 Free PMC article. Review.

8

Underestimation of risk by Gail model extends beyond women with atypical hyperplasia.

Amir E, Freedman O. Amir E, et al. Among authors: freedman o. J Clin Oncol. 2009 Mar 20;27(9):1526; author reply 1527. doi: 10.1200/JCO.2008.21.2175. Epub 2009 Feb 9. J Clin Oncol. 2009. PMID: 19204192 No abstract available.

9

Lapatinib plus paclitaxel as first-line therapy for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: inappropriate conclusions from a company-sponsored study?

Amir E, Seruga B, Freedman O, Tannock I. Amir E, et al. Among authors: freedman o. J Clin Oncol. 2009 Apr 10;27(11):1919; author reply 1920-1. doi: 10.1200/JCO.2008.21.2951. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255302 No abstract available.

10

Radiological changes following second-line zoledronic acid treatment in breast cancer patients with bone metastases.

Amir E, Whyne C, Freedman OC, Fralick M, Kumar R, Hardisty M, Clemons M. Amir E, et al. Among authors: freedman oc. Clin Exp Metastasis. 2009;26(5):479-84. doi: 10.1007/s10585-009-9247-x. Epub 2009 Mar 6. Clin Exp Metastasis. 2009. PMID: 19266291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters